Markets:

Overview

News

Currencies

International

Treasuries

CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.520 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CureVac N.V. - Ordinary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Dow Plummets as Fed Update, Jobless Data Weighs ↗

June 17, 2021

The Federal Reserve's accelerated interest rate timeline and inflation forecast is putting a damper on stocks today, with worse-than-expected weekly jobless claims only adding insult to injury.

Via Talk Markets

Topics Economy Stocks

Mid-Day Market Update: Gold Drops Over 4%; Midatech Pharma Shares Jump ↗

June 17, 2021

Midway through trading Thursday, the Dow traded down 0.35% to 33,913.86 while the NASDAQ rose 0.73% to 14,142.60. The S&P also rose, gaining 0.07% to 4,226.52. The U.S. has...

Via Benzinga

Topics Stocks

34 Stocks Moving In Thursday's Mid-Day Session ↗

June 17, 2021

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 68.5% to $5.51 after the company announced it filed a registration statement in connect with the proposed merger...

Via Benzinga

Why CureVac's Stock Is Trading Higher Today ↗

May 13, 2021

CureVac (NASDAQ:CVAC) shares are trading higher ...

Via Benzinga

Why CureVac Stock Is Getting Crushed Today ↗

June 17, 2021

The biotech's COVID-19 vaccine candidate no longer appears to be viable.

Via The Motley Fool

Mid-Morning Market Update: Markets Mixed; Kroger Earnings Top Views ↗

June 17, 2021

Following the market opening Thursday, the Dow traded down 0.29% to 33,935.28 while the NASDAQ rose 0.34% to 14,086.74. The S&P also fell, dropping 0.01% to 4,223.07. The U.S...

Via Benzinga

Topics Stocks

CureVac Stock Plummets After Covid Vaccine Fails In Interim Analysis ↗

June 17, 2021

CureVac stock plummeted Thursday after its messenger RNA-based Covid vaccine failed in an interim analysis. The vaccine was 47% effective against Covid of any severity.

Via Investor's Business Daily

CVAC Stock: The Huge Covid-19 News That Has CureVac Plunging Today ↗

June 17, 2021

CureVac shares crashed after the German biotech said its Covid-19 vaccine was only 47% effective in preventing the disease.

Via InvestorPlace

The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme ↗

June 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...

Via Benzinga

25 Stocks Moving in Thursday's Pre-Market Session ↗

June 17, 2021

Gainers Midatech Pharma plc (NASDAQ: MTP) rose 42.2% to $2.90 in pre-market trading after the company disclosed breakthrough data using Q-Sphera technology. Cellect...

Via Benzinga

Tesla-Backed CureVac Plunges On Underwhelming COVID-19 Vaccine Efficacy Data ↗

June 17, 2021

German vaccine developer, CureVac N.V. (NASDAQ: CVAC), may not be as fortunate as its domestic peer BioNTech SE (NASDAQ: BNTX), which along with its...

Via Benzinga

CureVac Provides Update on Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV

June 16, 2021

- Pivotal study conducted in 10 countries in fast changing environment of at least 29 COVID-19 variant strains; original strain almost completely absent - At second interim analysis, statistical...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

Unusual Options Activity Insight: CureVac ↗

June 16, 2021

CureVac (NASDAQ:CVAC) shares experienced unusual options activity on Wednesday. The stock price moved up to $99.74 following the option alert. Sentiment: BULLISH Option Type:...

Via Benzinga

Moderna, BioNTech Pop Despite Mounting Pressure On Covid Vaccine Patents ↗

June 10, 2021

The World Trade Organization is moving ahead with a plan that could waive Covid vaccine patents. But vaccine stocks weren't rattled Thursday.

Via Investor's Business Daily

Topics Intellectual Property

75 Biggest Movers From Yesterday ↗

June 09, 2021

Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock. NextDecade...

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

June 08, 2021

Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares jumped 72.4% to $20.55 amid increased retail investor interest in the stock. NextDecade Corporation (NASDAQ: NEXT...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Thor Industries Beats Q3 Estimates ↗

June 08, 2021

Following the market opening Tuesday, the Dow traded down 0.16% to 34,574.38 while the NASDAQ rose 0.32% to 13,926.79. The S&P also fell, dropping 0.04% to 4,224.95. The U.S....

Via Benzinga

Topics Stocks

Could CureVac Be a Millionaire-Maker Stock? ↗

June 08, 2021

This biotech's coronavirus vaccine candidate could be the next to hit the market -- but a lot of its potential success has been priced in.

Via The Motley Fool

CureVac Appoints Klaus Edvardsen as Chief Development Officer

June 02, 2021

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE /June 2, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

CureVac's COVID-19 Vaccine Is Safe, But Efficacy Not Yet Disclosed ↗

June 01, 2021

CureVac BV (NASDAQ: CVAC) said its first-generation COVID-19 vaccine candidate had passed its first interim analysis, but it was not yet ready to share efficacy data....

Via Benzinga

CureVac's First-Generation COVID-19 Vaccine Candidate, CVnCoV, Continues Toward Phase 2b/3 Efficacy Readout in Variant-rich Environment Following DSMB Recommendation

May 28, 2021

- Study continues to progress according to protocol following first interim analysis at 59 eligible COVID-19 cases - Sequencing data to be made available in parallel with efficacy data given...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

CureVac Announces Financial Results for the First Quarter of 2021 and Business Updates

May 26, 2021

- First-Generation COVID-19 vaccine program, CVnCoV - Phase 3 trial started with CVnCoV in adults suffering from selected comorbidities - Phase 2a trial in Peru and Panama assessing third booster...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

The Battle Over Covid Vaccine Patents Begins — What It Could Mean For Biotech ↗

May 20, 2021

Experts say a patent waiver for coronavirus shots wouldn't just pressure Covid vaccine stocks, it could also staunch innovation for biotech companies.

Via Investor's Business Daily

Topics Intellectual Property

CureVac-GSK's Second-Gen COVID-19 Vaccine Candidate Shows Encouraging Action Against Variants In Animal Study ↗

May 13, 2021

CureVac N.V. (NASDAQ: CVAC) and GlaxoSmithKline Plc (NYSE: GSK) have released positive early data from a preclinical study of its second-...

Via Benzinga

CureVac: Second-Generation COVID-19 Vaccine Candidate, CV2CoV, Demonstrates High Immunogenicity Against Virus Variants in Preclinical Study

May 13, 2021

- Second-generation lead COVID-19 vaccine candidate, CV2CoV, developed in collaboration by CureVac and GSK - CV2CoV mRNA shows high levels of antigen production in rat model - Fast onset of strong...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

What's Up WIth BioNTech Stock And CureVac Stock Today? ↗

May 10, 2021

BioNTech SE - ADR (NASDAQ: BNTX) shares were trading higher by 8.27% at $198.80 in Monday’s premarket session after the company announced a Chinese joint venture to...

Via Benzinga

70 Biggest Movers From Friday ↗

May 10, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1...

Via Benzinga

Week In Review: WHO Close To Approving Global Use For Two China COVID-19 Vaccines ↗

May 08, 2021

The World Health Organization approved Sinopharm's COVID-19 vaccine for emergency use, which will give poorer nations access to a vaccine against the pandemic. Sinovac's inactivated COVID-19 vaccine...

Via Talk Markets

56 Stocks Moving In Friday's Mid-Day Session ↗

May 07, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....

Via Benzinga

32 Stocks Moving in Friday's Pre-Market Session ↗

May 07, 2021

Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) shares rose 44.2% to $0.7190 in pre-market trading after the company reported better-than-expected Q1 results. iBio, Inc. (NYSE:...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.